| 000 | 01549 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518012401.0 | ||
| 264 | 0 | _c20190726 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1573-4935 | ||
| 024 | 7 |
_a10.1042/BSR20181767 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Xuan | |
| 245 | 0 | 0 |
_aAMPK: a therapeutic target of heart failure-not only metabolism regulation. _h[electronic resource] |
| 260 |
_bBioscience reports _c01 2019 |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xbiosynthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 |
_aCardiotonic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xcomplications |
| 650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aMyocardium _xenzymology |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 700 | 1 | _aLiu, Jia | |
| 700 | 1 | _aLu, Qingguo | |
| 700 | 1 | _aRen, Di | |
| 700 | 1 | _aSun, Xiaodong | |
| 700 | 1 | _aRousselle, Thomas | |
| 700 | 1 | _aTan, Yi | |
| 700 | 1 | _aLi, Ji | |
| 773 | 0 |
_tBioscience reports _gvol. 39 _gno. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/BSR20181767 _zAvailable from publisher's website |
| 999 |
_c29128519 _d29128519 |
||